Anti-cyclic Citrullinated Peptide Antibodies are Highly Associated with Severe Bone Lesions in Rheumatoid Arthritis Anti-CCP and Bone Damage in RA
2004; Informa; Volume: 37; Issue: 6-7 Linguagem: Inglês
10.1080/08916930400011965
ISSN1607-842X
AutoresSusanna Maddali Bongi, Roberto Manetti, Daniela Melchiorre, Stefano Turchini, Piero Boccaccini, Lorenzo Vanni, Enrico Maggi,
Tópico(s)Monoclonal and Polyclonal Antibodies Research
ResumoIn the present study we investigated the predictive value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in early rheumatoid arthritis (RA) with respect to the bone damage.Fifty-four patients with early RA (onset 12 months), 33 healthy donors and 76 non-RA autoimmune diseases, were enrolled. Anti-CCP and IgG, IgA, IgM rheumatoid factors (RFs) were determined at baseline. Disease activity score (DAS 28) was calculated at the entry. Bone involvement was evaluated by X-rays and sonography.The specificity of anti-CCP was 98.4%; significantly ( p<0.01) higher than those of the IgM- (86.0%), IgA- (86.0%) and IgG-RFs (66.2%), respectively. Anti-CCP were detected in 23/54 (42.6%) early RA patients and in 16/35 (45.7%) established RA patients. In the early RA group, 6/33 (18.2%) of the patients without bone lesions, 12/16 (75%) with juxta-articular osteoporosis (JO) and 5/5 with joint erosions (JE) resulted positive showing a significant ( p<0.001) difference between the groups without and with radiological damage.In the established RA group a significant ( p<0.01) difference being between the group without radiological damage and that with JE was found. Finally, in patients without radiological lesions, examined by ultrasound, anti-CCP antibodies were detected only in subjects with pathologic findings (31.25%).Data here reported confirm that the presence of anti-CCP are specific for diagnosis of RA, of recent onset also and they are potentially useful as prognostic index of bone involvement.
Referência(s)